The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02697630
Brief Title: Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye (PEMDAC)

First Submitted : February 22, 2016
First Submitted that Met QC Criteria : February 26, 2016
First Posted : March 3, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 1, 2023
Last Update Posted : December 8, 2023